Gainers
- Clearside Biomedical CLSD stock moved upwards by 26.21% to $3.81 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 52.1 million shares, making up 23606.79% of its average full-day volume over the last 100 days. The company's market cap stands at $219.4 million.
- Obalon Therapeutics OBLN shares moved upwards by 15.74% to $3.75. Trading volume for Obalon Therapeutics's stock is 2.0 million as of 12:30 EST. This is 53.99% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $37.5 million.
- Fusion Pharmaceuticals FUSN shares rose 13.48% to $9.26. Trading volume for this security as of 12:30 EST is 1.0 million, which is 2541.72% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $393.1 million.
- Citius Pharmaceuticals CTXR shares rose 12.9% to $3.1. Trading volume for this security as of 12:30 EST is 21.8 million, which is 358.18% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $420.6 million.
- Jounce Therapeutics JNCE shares increased by 12.89% to $7.89. Jounce Therapeutics's stock is trading at a volume of 1.8 million shares as of 12:30 EST. This is 528.04% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $404.1 million.
- Aptevo Therapeutics APVO shares rose 11.46% to $31.3. Trading volume for Aptevo Therapeutics's stock is 169.1K as of 12:30 EST. This is 342.26% of its average full-day volume over the last 100 days. The company's market cap stands at $139.2 million.
Losers
- PDS Biotechnology PDSB stock declined by 25.98% to $9.52 during Tuesday's regular session. The current volume of 5.1 million shares is 333.12% of PDS Biotechnology's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $212.0 million.
- Sage Therapeutics SAGE shares declined by 17.56% to $60.07. As of 12:30 EST, this security is trading at a volume of 5.3 million shares, making up 1079.09% of its average full-day volume over the last 100 days. The company's market cap stands at $3.5 billion.
- NeuroBo Pharmaceuticals NRBO shares decreased by 16.76% to $3.28. As of 12:30 EST, this security is trading at a volume of 534.2K shares, making up 227.86% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $72.7 million.
- Anavex Life Sciences AVXL stock fell 15.25% to $17.79. As of 12:30 EST, this security is trading at a volume of 3.6 million shares, making up 258.85% of its average full-day volume over the last 100 days. The company's market cap stands at $1.2 billion.
- Enochian BioSciences ENOB shares declined by 14.44% to $5.81. Trading volume for this security as of 12:30 EST is 6.7 million, which is 360.31% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $277.6 million.
- Cyclerion Therapeutics CYCN shares fell 12.24% to $3.77. The current volume of 1.1 million shares is 100.08% of Cyclerion Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $152.1 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in